ClinicalTrials.Veeva

Menu

Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Covid19

Treatments

Diagnostic Test: Nasopharyngeal swab for COVID-19 testing

Study type

Interventional

Funder types

Other

Identifiers

NCT04840082
21015626

Details and patient eligibility

About

This study aim to explore the optimal swap insertion length for mid-turbinate and nasopharyngeal samples. Our clinical trial took place at a Covid-19 test center in Copenhagen. Participants consisted of voluntary citizens who were at the test center for a nasopharyngeal antigen quicktest. An endoscopic examination was performed simultaneous with the swap to measure the length from the vestibulum nasi to the posterior wall of the nasopharynx and the mid-turbinate.

Enrollment

109 patients

Sex

All

Ages

16+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Referred for COVID-19 testing

Exclusion criteria

  • Nose patology

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

109 participants in 1 patient group

Collecting of Clinical Specimens for COVID-19 Testing
Experimental group
Description:
Nasopharyngeal swab is performed on all participants to collect specimens for Rapid antigen COVID-19 Testing
Treatment:
Diagnostic Test: Nasopharyngeal swab for COVID-19 testing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems